Brief: Caladrius Biosciences Announces Approval Of Merger And Name Change To Lisata Therapeutics
14/09/2022 13:59
Sept 14 (Reuters) - Caladrius Biosciences Inc CLBS.O :
* CALADRIUS BIOSCIENCES ANNOUNCES APPROVAL OF MERGER AND
NAME
CHANGE TO LISATA THERAPEUTICS
Source text for Eikon: ID:nGNX2g2v4Y
Further company coverage: CLBS.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal